Company / Assets per Share
Beam Therapeutics Inc. Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$14.56
FY2025
5-year range
$13.20 / $21.56
FY2021-FY2025
Trend
+10.3%
vs FY2024
Sector context
#70 of 210
Health Care
What the data says
At $14.56, Beam Therapeutics Inc.'s assets per share ranks #70 of 210 in the Health Care sector. Assets per Share returned to growth in FY2025 after 4 years of decline, reaching $14.56.
Based on SEC 10-K filings.
14.56 in FY2025 with a 5-year CAGR of -25.1%.
Declined from $17.88 to $14.56 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -8.2%
- 5-Year CAGR
- -25.1%
- 10-Year CAGR
- -
Sector benchmark
#70 of 210 in Health CareTop 33% of 210This company $14.56 Sector average $353.15
▼
-95.9% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 10.3% year-over-year.
- Ranks #70 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.56 | +10.3% |
| FY2024 | $13.20 | -26.2% |
| FY2023 | $17.88 | -5.0% |
| FY2022 | $18.82 | -12.7% |
| FY2021 | $21.56 | -65.0% |
| FY2020 | $61.65 | +155.9% |
| FY2019 | $24.09 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026